A detailed history of Gwn Securities Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gwn Securities Inc. holds 14,165 shares of BMY stock, worth $663,063. This represents 0.15% of its overall portfolio holdings.

Number of Shares
14,165
Previous 9,766 45.04%
Holding current value
$663,063
Previous $453 Million 41.52%
% of portfolio
0.15%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025

BUY
$43.31 - $48.98 $190,520 - $215,463
4,399 Added 45.04%
14,165 $641 Million
Q2 2025

Aug 01, 2025

SELL
$44.12 - $59.6 $2.91 Million - $3.92 Million
-65,854 Reduced 87.09%
9,766 $453 Million
Q1 2025

May 15, 2025

BUY
$53.9 - $63.11 $3.55 Million - $4.16 Million
65,917 Added 679.35%
75,620 $3.43 Billion
Q4 2024

Feb 10, 2025

BUY
$51.92 - $59.94 $503,779 - $581,597
9,703 New
9,703 $576 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gwn Securities Inc. Portfolio

Follow Gwn Securities Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gwn Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gwn Securities Inc. with notifications on news.